A GLP-1:CCK fusion peptide harnesses the synergistic effects on metabolism of CCK-1 and GLP-1 receptor agonism in mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A GLP-1:CCK fusion peptide harnesses the synergistic effects on metabolism of CCK-1 and GLP-1 receptor agonism in mice

Published:2018-08 Issue: Volume:127 Page:334-340
ISSN:0195-6663
Container-title:Appetite
language:en
Short-container-title:Appetite

Author:

Hornigold David C.,Roth Emma^ORCID,Howard Victor,Will Sarah,Oldham Stephanie,Coghlan Matthew P.,Blouet Clemence^ORCID,Trevaskis James L.

Funder

Medical Research Council Metabolic Disease Unit

Wellcome Trust Strategic award for the MRL Disease Model Core and Imaging facilities

Publisher

Elsevier BV

Subject

Nutrition and Dietetics,General Psychology

Reference18 articles.

1. Brain regions where cholecystokinin suppresses feeding in rats;Blevins;Brain Research,2000

2. Use of the site-specific retargeting jump-in platform cell line to support biologic drug discovery;Butler;Journal of Biomolecular Screening,2015

3. Pharmacology, physiology, and mechanisms of incretin hormone action;Campbell;Cell Metab,2013

4. Revitalization of pioglitazone: The optimum agent to be combined with a sodium-glucose co-transporter-2 inhibitor;DeFronzo;Diabetes, Obesity and Metabolism,2016

5. Emerging opportunities for the treatment of metabolic diseases: Glucagon-like peptide-1 based multi-agonists;Finan;Molecular and Cellular Endocrinology,2015

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of novel glucagon-like peptide 1/cholecystokinin 1 receptor dual agonists;European Journal of Pharmaceutical Sciences;2024-08

2. The role of gut microbiota in anorexia induced by T-2 toxin;Ecotoxicology and Environmental Safety;2024-08

3. Glucagon-like peptide-1 analogs: Miracle drugs are blooming?;European Journal of Medicinal Chemistry;2024-04

4. Advances in obesity pharmacotherapy; learning from metabolic surgery and beyond;Metabolism;2024-02

5. Nonalcoholic fatty liver disease: Current therapies and future perspectives in drug delivery;Journal of Controlled Release;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3